CTOs on the Move

Impel NeuroPharma

www.impelneuropharma.com

 
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Impel NeuroPharma raised $36M on 12/02/2016
Impel NeuroPharma raised $67.5M on 12/06/2018

Similar Companies

CellaVision

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services.

CommonHealth

CommonHealth comprises Altum, Carbon, CommonHealth London, CommonHealth Paris, Conectics, Earthborn, EvoLogue, Ferguson, HLS, MBS/Vox, ProCom, Qi, Solara and Valos.

GCX Corporation

GCX Corporation is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lakeshore Biomaterials Inc

Lakeshore Biomaterials Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arch Air Medical

Arch Air Medical is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.